Clinical Trial Update: A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)

View source ↗

Summary

Prospective observational study in adults with Retinitis Pigmentosa, sponsored by Sumitomo Pharma America, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Retinitis Pigmentosa | Status: ACTIVE_NOT_RECRUITING